After Bristol Rovers’ 2-1 win against Salford City in late September, the Gas extended their unbeaten run in all competitions ...
Niktimvo (axatilimab-csfr) is a first-in-class colony stimulating factor-1 receptor (CSF-1R)-blocking antibody approved for use in the U.S. for the treatment of chronic graft-versus-host disease (GVHD ...